PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026Journal of Asian Natural Products Research0 citations

Transcriptomic profile and gene expression of human breast cancer cell lines treated with herbal extract of clinacanthus nutans leaves

View Full Paper
ZTZaleha Md TohaNHNorhasyimah HaronKAKristine Sandra Pey Adum

Key Points

  • The research aims to explore the apoptotic effects of Clinacanthus nutans extract on human breast cancer cells.
  • Utilized dichloromethane leaf extract of Clinacanthus nutans
  • Conducted RNA-Seq analysis on MCF-7 breast cancer cells
  • Performed differential gene expression analysis
  • Utilized gene ontology and KEGG pathway analyses
  • Validated key genes with RT-qPCR
  • Identified 843 differentially expressed genes, with 395 upregulated and 448 downregulated
  • Revealed significant apoptosis-associated pathways
  • Validated key genes related to apoptosis such as ALDH3A1 and CYP1A1

Abstract

Clinacanthus nutans (CN) is traditionally used in medicine, but its apoptotic effects on breast cancer cells remain unclear. This study investigated the apoptotic potential of CN dichloromethane leaf extract (CNDCM) in MCF-7 cells using RNA-Seq analysis. Differential gene expression analysis identified 843 genes, with 395 upregulated and 448 downregulated. Gene ontology and KEGG pathway analyses revealed apoptosis-related pathways. Key apoptosis-associated genes, including ALDH3A1, CYP1A1, NOS3, MT1X, and CES1, were further validated by RT-qPCR. These findings suggest CNDCM as a potential candidate for breast cancer therapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Toha et al. (2026) studied this question.

synapsesocial.com/papers/698827a20fc35cd7a8846758https://doi.org/10.1080/10286020.2026.2625174
Ask AI
Helpful
Bookmark
Share
View Full Paper